Gowri Gopalakrishna to speak at DRIVE-AB Final Conference in Brussels
Gowri Gopalakrishna will join a panel discussion at the DRIVE-AB Final Conference: Revitalizing the antibiotic pipeline, in Brussels, Belgium. Gowri will present the methodology for the 2018 Antimicrobial Resistance Benchmark 2018, which has been developed to map how pharma companies are responding to AMR, as well as the synergies between the Benchmark and the DRIVE-AB results.
Date
06 September 2017
The event, organized by the Drive-AB Consortium, will bring together global policy- and decision-makers, regulatory and public health experts, economists and representatives of the pharmaceutical, medical and civil society communities from across the globe to discuss the consortium’s final recommendations and their implementation.
Gowri will speak in a panel focused on the Drive A/B project’s key findings and the best strategies for moving forward. She will discuss the Methodology for the 2018 Antimicrobial Resistance Benchmark and the synergies between the Benchmark and the DRIVE-AB results.